BHC Bausch Health Companies Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$5.37

Period return

-1.45 (-21.26%)

Volume

1.8M

2026-06-05O $5.27 H $5.39 L $5.16 C $5.37MA5 $5.18MA20 $5.36MA60 $5.41MA120 $5.91

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 04. 28.Lowlast month
RBC Capital: r Perform
US analyst rating / recommendation change.
2026. 02. 26.LowHOLD3 months ago
Barclays: Equal-Weight
US analyst rating / recommendation change.
2026. 01. 07.LowHOLD5 months ago
Truist Securities: Hold
US analyst rating / recommendation change.
2025. 12. 10.Medium

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $7.5 · 6 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ: Laval, QC, Canada
Fiscal year end: —
Employees: 20,300
IPO date: —

View details →

Barclays: Equal-Weight